1/26/2012

The FDA approved LEO Pharma's Picato gel to treat actinic keratosis, a premalignant skin condition resulting from too much sun exposure. Phase III studies found that more patients who used Picato saw lesions disappear than those given placebo.

Full Story:
MedCityNews.com

Related Summaries